Novel EU-funded collaborative proteomics project to bring proteomics to clinical application

Novel proteomic technologies that are so robust and powerful that they can be used in every biological laboratory and in every clinic are expected as results of the currently starting research consortium MSmed. The European Commis­sion is co-funding the project with 3.7 Million Euros for four years starting Dec. 1, 2015 within the research line “Future and Emerging Technologies” under the Horizon 2020 Pro­gramme. MSmed will automate workflows in mass spectrometric analysis for proteomics re­search to prepare them for high-throughput clinical application.

Proteins At Work is a project in the NWO National Roadmap for Large-Scale Research Facilities programme which encourages the establishment or improvement of large research facilities with which the Netherlands can assume an important position internationally. Proteins At Work will make high-level technology, equipment and expertise for studying proteins in cells and tissues available to the biological and biomedical researchers in the Netherlands. The Proteins At Work programme is a collaboration between Utrecht University, the UMC Utrecht, the Hubrecht Institute, the Erasmus MC Rotterdam and the Netherlands Cancer Institute and is coordinated by prof. dr. Albert Heck.

• dr. Geert Kops
• prof. dr. A.F.M. (Maarten) Altelaar
• dr. R. (Reinout) Raijmakers
• drs. Martje Ebberink

• prof. dr. Roland Kanaar (Erasmuc MC)
• dr. Jeroen Demmers (Erasmus MC)
• dr. Harm-Jan Vos (UMCU)
• prof. dr. Rene Medema (NKI)
• prof. dr. Hans Clevers (Hubrecht Institute)

The Institute for Chemical Immunlogy is an NWO Gravitation project coordinator by Leiden University. It will define and exploit a new field termed chemical immunology and train a novel generation of interdisciplinary scientists. It aims to promote academic excellence; with economic and clinical translation of new treatment options for a large population of patients that currently only have limited treatment options.

• prof. dr. C.R. (Celia) Berkers
• drs. Martje Ebberink
• dr. R. (Reinout) Raijmakers

• prof. dr. Sjaak Neefjes (NKI; coordinator)
• prof. dr. Hermen Overkleeft (LU)
• prof. dr. Carl Figdor (RU)
• prof. dr. Ton Schumacher (NKI)

ManiFold is an Innovative Doctoral Programme organised by members of the Bijvoet Center for Biomolecular Research and its Graduate Research School, at Utrecht University in the Netherlands. The European Union selected the most innovative doctoral programmes in Europe for funding in the prestigious Marie-Curie Initial Training Networks scheme. ManiFold was the only Innovative Doctoral Programme in the Life Sciences funded in 2012.

• dr. H. (Hugo) van Ingen
• prof. dr. R. (Rolf) Boelens
• prof. dr. ir. B.J.C. (Bert) Janssen
• prof. dr. J.A. (Antoinette) Killian
• dr. R. (Reinout) Raijmakers

PRIME-XS provides European Union funded access to an infrastructure of state-of-the-art proteomics technology to the biological and biomedical research community in Europe. European researchers who would like to use proteomics technology for their research can apply with a research proposal on this website. PRIME-XS is a consortium of twelve partners, all leading in the field of proteomics. In addition to providing access, we develop new technologies to better aid the research community in answering current day scientific questions, and organize courses and meetings.

• dr. R. (Reinout) Raijmakers
• prof. dr. A.F.M. (Maarten) Altelaar

• Flemish Institute for Biotechnology
• University of Zurich
• Eidgenössische Technische Hochschule Zurich
• University of Copenhagen
• Center for Genomic Regulation
• University of Cambridge
• Research Institute of Molecular Pathology
• Commissariat à l'énergie atomique
• Eberhard Karls Universität Tübingen
• European Bioinformatics Institute
• Max Planck Institute of Biochemistry